Unique Case of Pseudoprogression Manifesting as Lung Cavitation After Pembrolizumab Treatment
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference4 articles.
1. Pseudoprogression and immune-related response in solid tumors;Chiou;J Clin Oncol,2015
2. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics;Seymour;Lancet Oncol,2017
3. Hyperprogressive disease is a new pattern of progression in cancer patients treated by anti-PD-1/PD-L1;Champiat;Clin Cancer Res,2017
4. Diffuse pseudoprogression in a patient with metastatic non–small-cell lung cancer treated with Nivolumab;Curioni-Fontecedro;Ann Oncol,2017
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Influence of Tumor Cavitation on Assessing the Clinical Benefit of Anti-PD1 or PD-L1 Inhibitors in Advanced Lung Squamous Cell Carcinoma;Clinical Lung Cancer;2024-01
2. Cardiac tamponade during pembrolizumab treatment in a patient with ovarian cancer: a case report;International Cancer Conference Journal;2023-07-05
3. Tumor Hyperprogression and Pseudoprogression After Immunotherapy;Handbook of Cancer and Immunology;2023
4. Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology;Acta Neuropathologica Communications;2022-02-10
5. Peritoneal Recurrence of Cecal Cancer with Specific Imaging Findings and Shrinkage after Treatment with Pembrolizumab;Journal of the Anus, Rectum and Colon;2022-01-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3